Locomotion Is Increased in A11-Lesioned Mice With Iron Deprivation
Open Access
- 1 May 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 66 (5), 383-388
- https://doi.org/10.1097/nen.0b013e3180517b5f
Abstract
Restless legs syndrome (RLS) is a common neurologic condition involving iron and dopamine systems. We sought to create an animal model consistent with RLS based on current understanding of human pathology. We performed bilateral 6-hydroxydopamine (6-OHDA) lesioning in the A11 nucleus of C57BL/6 mice and deprived a subset of mice from dietary iron to observe whether these manipulations can increase motor activity. Iron levels in serum, brain, and especially spinal cord were significantly decreased after iron deprivation. Interestingly, 6-OHDA lesioning appeared to further reduce CNS iron stores. Pathologic examination demonstrated a 94% reduction in A11 tyrosine hydroxylase staining cells in mice injected with 6-OHDA but minimal effects on other areas. Locomotor activities were significantly increased in both the mice that were iron deprived and the A11-lesioned mice compared with controls. The combination of iron deprivation and A11 lesions further significantly augmented activity. Additionally, the mice in the combined iron-deprived and lesioned group were more aggressive. The increased activity in A11-lesioned mice with or without iron deprivation was normalized after treatment with the D2/D3 agonist ropinirole, as is seen in human RLS but was worsened by the D1 agonist SKF38393. This model could be consistent with human RLS, attention deficit hyperactivity disorder, or akathisia.Keywords
This publication has 20 references indexed in Scilit:
- Spinal cord dopamine receptor expression and function in mice with 6‐OHDA lesion of the A11 nucleus and dietary iron deprivationJournal of Neuroscience Research, 2007
- Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12‐week, double‐blind, randomized, parallel‐group, placebo‐controlled studyMovement Disorders, 2004
- Thy1 expression in the brain is affected by iron and is decreased in Restless Legs SyndromeJournal of the Neurological Sciences, 2004
- Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care studySleep Medicine, 2004
- Restless legs syndrome: diagnostic criteria, special considerations, and epidemiologySleep Medicine, 2003
- Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: A possible model for restless legs syndrome?Movement Disorders, 2000
- The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- LOW SERUM IRON STATUS AND AKATHISIAThe Lancet, 1987
- Effect of Iron Chelators on Dopamine D2 ReceptorsJournal of Neurochemistry, 1985
- The effects of therapy on the developmental scores of iron-deficient infantsThe Journal of Pediatrics, 1978